Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 5.

Journal Article

Abdulla, Diana S. Y., Scheffler, Matthias ORCID: 0000-0002-9031-1368, Brandes, Vanessa, Ruge, Maximilian, Kunze, Sabine, Merkelbach-Bruse, Sabine, Nogova, Lucia, Michels, Sebastian, Fischer, Rieke, Riedel, Richard, Buettner, Reinhard, Persigehl, Thorsten, Grau, Stefan, Galldiks, Norbert ORCID: 0000-0002-2485-1796, Drzezga, Alexander ORCID: 0000-0001-6018-716X, Kobe, Carsten and Wolf, Juergen (2019). Monitoring Treatment Response to Erlotinib in EGFR-mutated Non-small-cell Lung Cancer Brain Metastases Using Serial O-(2[F-18]fluoroethyl)-L-tyrosine PET. Clin. Lung Cancer, 20 (2). S. E148 - 4. DALLAS: CIG MEDIA GROUP, LP. ISSN 1938-0690

Michels, Sebastian, Massuti, Bartomeu, Schildhaus, Hans-Ulrich, Franklin, Jeremy ORCID: 0000-0003-1536-0925, Sebastian, Martin, Felip, Enriqueta, Grohe, Christian, Rodriguez-Abreu, Delvys, Abdulla, Diana S. Y., Bischoff, Helge, Brandts, Christian, Carcereny, Enric, Corral, Jesus, Dingemans, Anne-Marie C., Pereira, Eva, Fassunke, Jana, Fischer, Rieke N., Gardizi, Masyar, Heukamp, Lukas ORCID: 0000-0002-3388-3482, Insa, Amelia, Kron, Anna, Menon, Roopika, Persigehl, Thorsten, Reck, Martin, Riedel, Richard, Rothschild, Sacha I., Scheel, Andreas H., Scheffler, Matthias, Schmalz, Petra, Smit, Egbert F., Limburg, Meike, Provencio, Mariano, Karachaliou, Niki, Merkelbach-Bruse, Sabine, Hellmich, Martin, Nogova, Lucia, Buettner, Reinhard, Rosell, Rafael and Wolf, Juergen (2019). Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial. J. Thorac. Oncol., 14 (7). S. 1266 - 1277. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380

Michels, Sebastian, Scheffler, Matthias, Wagener, Svenja, Plenker, Dennis, Scheel, Andreas, Nogova, Lucia, Schultheis, Anne, Fischer, Rieke N., Abdulla, Diana S. Y., Riedel, Richard, Bunck, Anne, Kobe, Carsten, Baus, Wolfgang, Merkelbach-Bruse, Sabine, Sos, Martin L., Buttner, Reinhard and Wolf, Jurgen (2018). Loss of G2032R Resistance Mutation Upon Chemotherapy Treatment Enables Successful Crizotinib Rechallenge in a Patient With ROS1-Rearranged NSCLC. JCO Precis. Oncol., 2. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 2473-4284

Riedel, Richard, Michels, Sebastian, Heydt, Carina, Siemanowski, Janna, Kobe, Carsten, Bunck, Anne, Schaefer, Stephan, Fischer, Rieke N., Scheffler, Matthias, Abdulla, Diana S. Y., Nogova, Lucia, Koleczko, Sophia, Merkelbach-Bruse, Sabine, Buettner, Reinhard and Wolf, Juergen (2019). Acquired KRAS mutation and loss of low-level MET amplification after durable response to crizotinib in a patient with lung adenocarcinoma. Lung Cancer, 133. S. 20 - 23. CLARE: ELSEVIER IRELAND LTD. ISSN 1872-8332

Scheffler, Matthias, Ihle, Michaela A., Hein, Rebecca, Merkelbach-Bruse, Sabine, Scheel, Andreas H., Siemanowski, Janna, Braegelmann, Johannes, Kron, Anna, Abedpour, Nima, Ueckeroth, Frank, Schueller, Merle, Koleczko, Sophia, Michels, Sebastian, Fassunke, Jana, Pasternack, Helen, Heydt, Carina, Serke, Monika, Fischer, Rieke, Schulte, Wolfgang, Gerigk, Ulrich, Nogova, Lucia, Ko, Yon-Dschun, Abdulla, Diana S. Y., Riedel, Richard, Kambartel, Karl-Otto, Lorenz, Joachim, Sauerland, Imke, Randerath, Winfried, Kaminsky, Britta, Hagmeyer, Lars, Grohe, Christian, Eisert, Anna, Frank, Rieke, Gogl, Leonie, Schaepers, Carsten, Holzem, Alessandra, Hellmich, Martin, Thomas, Roman K., Peifer, Martin, Sos, Martin L., Buettner, Reinhard and Wolf, Juergen (2019). K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic Pathways. J. Thorac. Oncol., 14 (4). S. 606 - 617. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380

This list was generated on Sun Jan 24 02:56:27 2021 CET.